Skip to content
Governance Register

← US public companies

Repare Therapeutics Inc.

SEC CIK 1808158 · RPTX · last insider filing 2026-01-30

Directors (from insider filings)

NameCapacity as filedFilings
Rhoads ANN D Director filed 2020 - 2026
Schafer Carol Director filed 2020 - 2026
Civik Thomas Director filed 2021 - 2026
Segal Lloyd Mitchell Director · President and CEO filed 2020 - 2025
Molineaux Susan Director filed 2023 - 2024
Bonita David P Director filed 2020 - 2024
Morrison Briggs Director filed 2020 - 2024
Stein Steven H Director filed 2024 - 2024
Kulkarni Samarth Director filed 2020 - 2024
Foley Todd Director filed 2020 - 2023
Jerel Davis Director filed 2020 - 2023
Orbimed Advisors LLC Director filed 2020 - 2021
Orbimed Capital LLC Director filed 2020 - 2021
Orbimed Capital GP VII LLC Director filed 2020 - 2021

Officers (from insider filings)

NameTitle as filedFilings
Forte Steve EVP, Chief Financial Officer filed 2020 - 2026
Alves Sandra Isabelle Barros SVP, Finance and CAO filed 2025 - 2026
Zinda Michael EVP, Chief Scientific Officer filed 2020 - 2025
Koehler Maria EVP, Chief Medical Officer filed 2020 - 2025

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.